Ubs Asset Management Americas Inc Applied Therapeutics Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.76 - $2.64 $17,248 - $59,914
-22,695 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$14.05 - $25.04 $318,864 - $568,282
22,695 New
22,695 $471,000
Q3 2020

Nov 13, 2020
SELL
$19.43 - $35.36 $117,881 - $214,529
-6,067 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$29.41 - $51.23 $178,430 - $310,812
6,067 New
6,067 $219,000

Others Institutions Holding APLT

# of Institutions
140
Shares Held
112M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $42.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email